123 related articles for article (PubMed ID: 33134179)
21. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF
Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191
[TBL] [Abstract][Full Text] [Related]
22. Serum HE4 level is an independent prognostic factor in epithelial ovarian cancer.
Kong SY; Han MH; Yoo HJ; Hwang JH; Lim MC; Seo SS; Yoo CW; Kim JH; Park SY; Kang S
Ann Surg Oncol; 2012 May; 19(5):1707-12. PubMed ID: 21833668
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of serum HE4 levels and risk of ovarian malignancy algorithm scores at the time of ovarian cancer diagnosis.
Kaijser J; Van Belle V; Van Gorp T; Sayasneh A; Vergote I; Bourne T; Van Calster B; Timmerman D
Int J Gynecol Cancer; 2014 Sep; 24(7):1173-80. PubMed ID: 24987915
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of Bmi-1 in uterine cervical cancer: correlation with clinicopathology and prognosis.
Zhang X; Wang CX; Zhu CB; Zhang J; Kan SF; Du LT; Li W; Wang LL; Wang S
Int J Gynecol Cancer; 2010 Dec; 20(9):1597-603. PubMed ID: 21370603
[TBL] [Abstract][Full Text] [Related]
25. Serum human epididymis protein 4 is associated with the treatment response of concurrent chemoradiotherapy and prognosis in patients with locally advanced non-small cell lung cancer.
Lan WG; Hao YZ; Xu DH; Wang P; Zhou YL; Ma LB
Clin Transl Oncol; 2016 Apr; 18(4):375-80. PubMed ID: 26329292
[TBL] [Abstract][Full Text] [Related]
26. Elevated serum concentrations of HE4 as a novel biomarker of disease severity and renal fibrosis in kidney disease.
Wan J; Wang Y; Cai G; Liang J; Yue C; Wang F; Song J; Wang J; Liu M; Luo J; Li L
Oncotarget; 2016 Oct; 7(42):67748-67759. PubMed ID: 27589683
[TBL] [Abstract][Full Text] [Related]
27. Preoperative markers for the prediction of high-risk features in endometrial cancer.
Panyavaranant P; Manchana T
World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
[TBL] [Abstract][Full Text] [Related]
28. Human epididymis protein 4 (HE4) and ovarian cancer prognosis.
Trudel D; Têtu B; Grégoire J; Plante M; Renaud MC; Bachvarov D; Douville P; Bairati I
Gynecol Oncol; 2012 Dec; 127(3):511-5. PubMed ID: 22967799
[TBL] [Abstract][Full Text] [Related]
29. Serum HE4 superior to CA125 in predicting poorer surgical outcome of epithelial ovarian cancer.
Shen Y; Li L
Tumour Biol; 2016 Nov; 37(11):14765-14772. PubMed ID: 27629144
[TBL] [Abstract][Full Text] [Related]
30. Role of serum HE4 as a prognostic marker in carcinoma of the ovary.
Lakshmanan M; Kumar V; Chaturvedi A; Misra S; Gupta S; Akhtar N; Rajan S; Jain K; Garg S
Indian J Cancer; 2019; 56(3):216-221. PubMed ID: 31389384
[TBL] [Abstract][Full Text] [Related]
31. Prognosis for different patterns of distant metastases in patients with uterine cervical cancer: a population-based analysis.
Zhang Y; Guo Y; Zhou X; Wang X; Wang X
J Cancer; 2020; 11(6):1532-1541. PubMed ID: 32047560
[No Abstract] [Full Text] [Related]
32. Serum HE4 levels combined with CE CT imaging improve the management of monitoring women affected by epithelial ovarian cancer.
Manganaro L; Michienzi S; Vinci V; Falzarano R; Saldari M; Granato T; Viggiani V; Frati L; Anastasi E
Oncol Rep; 2013 Nov; 30(5):2481-7. PubMed ID: 23970060
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic Performance of Serum Human Epididymis Protein 4 in Endometrial Carcinoma: A Pilot Study.
Dewan R; Dewan A; Hare S; Bhardwaj M; Mehrotra K
J Clin Diagn Res; 2017 Jul; 11(7):XC01-XC05. PubMed ID: 28893024
[TBL] [Abstract][Full Text] [Related]
34. [Clinical value of combined detection of serum human epididymal secretory protein E4 and CA(125) in the diagnosis of endometrial carcinoma].
Zhang AM; Zhang P
Zhonghua Fu Chan Ke Za Zhi; 2012 Feb; 47(2):125-8. PubMed ID: 22455745
[TBL] [Abstract][Full Text] [Related]
35. Expression and clinical significance of annexin A2 and human epididymis protein 4 in endometrial carcinoma.
Deng L; Gao Y; Li X; Cai M; Wang H; Zhuang H; Tan M; Liu S; Hao Y; Lin B
J Exp Clin Cancer Res; 2015 Sep; 34(1):96. PubMed ID: 26362938
[TBL] [Abstract][Full Text] [Related]
36. Serum human epididymis protein 4 concentrations are associated with severity of patients with pulmonary tuberculosis.
Li L; Yao Y; Liang J; Zhan X; Wang F; Yue C; Wu BQ; Hu S; Liu M; Wan J; Luo J
Clin Chim Acta; 2020 Mar; 502():255-260. PubMed ID: 31730821
[TBL] [Abstract][Full Text] [Related]
37. B7-H4 expression is correlated with tumor progression and clinical outcome in urothelial cell carcinoma.
Fan M; Zhuang Q; Chen Y; Ding T; Yao H; Chen L; He X; Xu X
Int J Clin Exp Pathol; 2014; 7(10):6768-75. PubMed ID: 25400757
[TBL] [Abstract][Full Text] [Related]
38. Clinical value of human epididymis protein 4 and the Risk of Ovarian Malignancy Algorithm in differentiating borderline pelvic tumors from epithelial ovarian cancer in early stages.
Kotowicz B; Fuksiewicz M; Sobiczewski P; Spiewankiewicz B; Jonska-Gmyrek J; Skrzypczak M; Kowalska M
Eur J Obstet Gynecol Reprod Biol; 2015 Nov; 194():141-6. PubMed ID: 26398337
[TBL] [Abstract][Full Text] [Related]
39. Stability of HE4 and CA125 in blood samples from patients diagnosed with ovarian cancer.
Sandhu N; Karlsen MA; Høgdall C; Laursen IA; Christensen IJ; Høgdall EV
Scand J Clin Lab Invest; 2014 Sep; 74(6):477-84. PubMed ID: 24724578
[TBL] [Abstract][Full Text] [Related]
40. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
